As of 2024-12-14, the Fair Value of Vanda Pharmaceuticals Inc (VNDA) is -7.03 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.61 USD, the upside of Vanda Pharmaceuticals Inc is -252.41%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | 115.60 | 23.30 | 33.20 | 6.30 | 2.51 | 36.18 |
| YoY growth | 358.73% | -79.84% | 42.49% | -81.02% | -60.17% | 36.04% |
| Market Cap (mil) | 268.81 |
| P/E | |
| Forward P/E | 50.52x |
| EPS | -0.28 |
| Avg earnings growth rate | 36.04% |
| TTM earnings | -16.39 |